(CIDRAP News) Federal health officials said today that only 35 people in the United States have "probable" cases of severe acute respiratory syndrome (SARS), a small fraction of the 208 suspected cases under investigation.
(CIDRAP News) Available diagnostic tests for SARS (severe acute respiratory syndrome) are not sensitive enough to reliably detect the SARS virus in the first few days of illness, a limitation that makes the disease harder to control, the World Health Organization (WHO) said today.
(CIDRAP News) – A US Food and Drug Administration (FDA) panel today recommended that the agency approve the nation's first H5N1 influenza vaccine, despite new evidence that the vaccine is less protective than reported in a clinical trial last year.
(CIDRAP News) This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.
(CIDRAP News) – China's State Food and Drug Administration (SFDA) yesterday approved the country's first prepandemic H5N1 influenza vaccine, an inactivated whole-virus product made by Sinovac, a Beijing-based biotechnology company.
(CIDRAP News) – The US Department of Health and Human Services (HHS) has accepted the first batch of H5N1 avian influenza vaccine based on the H5N1 variant known as clade 2.2, which has spread most widely across Asia, Europe, and Africa.
Indonesia reports H5N1 outbreak on BaliAn animal health official on Indonesia's Bali island reported an H5N1 outbreak in chickens in Badung district, which led to the recent culling of 133 birds, the Jakarta Globe reported today. A man who experienced flu-like symptoms after he was exposed to sick birds was treated with oseltamivir and appears to be improving, the report said.